Company Overview and News
Zhaojin Mining Industry, one of China’s largest gold producers, plans to spend 120 million yuan (US$18.9 million) this year on technology to enable “smart and automated” operations at some of its mines, as part of a long-term strategy to counter rising labour costs.
TIANJIN, China Sept 24 (Reuters) - As far as China’s miners are concerned, the modern-day Silk Road is paved with gold.
Hong Kong has welcomed its first exchange traded fund (ETF) that tracks gold mining companies around the world, though investors were warned of increased volatility as gold mining stocks see trading that is typically three times sharper than gold prices.
President-elect Trump’s promise of rebuilding the country’s creaking infrastructure sparked life into aluminium-, copper-, iron- and coal-related businesses
Hong Kong-listed company has spent 7.9bn yuan since 2010 on 13 transactions around the world, more than double what it has invested in domestic mines
Hong Kong stocks were mixed in late morning trade Thursday, after negative cues from US markets overnight where stocks finished slightly lower after the Federal Reserve issued an upbeat report card on the economy.
Hang Seng closes at 23,741.81. Shanghai extends its 4-day winning streak, after the SCI ends the day 0.04pc ahead at 3,091.93
Hong Kong stocks dipped in reaction to a US firm calling off a high-speed train deal with China.
Gold shares rally after reports said George Soros is back to the market with bearish investments, favouring gold and gold-mining shares
EGO sold its four Chinese mines for a total of $900 million. First in April 27, 2016, the Jinfeng mine and today the three remaining properties, including one project.
EGO has reached an agreement to sell its 82 percent interest in its Jinfeng mine to China National Gold Group for US$300 million in cash.
Gold Mining ETFs have been firing on all cylinders lately thanks to the dual favor by a dovish Fed and an aggressive China. The Fed seems to be in no hurry to hike interest rates this year and has hinted at just two hikes this year dampening the greenback and propelling the broader commodities including gold.
Gold Mining ETFs have been firing on all cylinders lately thanks to the dual favor by a dovish Fed and an aggressive China. The Fed seems to be in no hurry to hike interest rates this year and has hinted at just two hikes this year dampening the greenback and propelling the broader commodities including gold. In fact, a volatile market outlook, which is making places for safe-haven assets like gold and a sagging dollar, led the gold bullion to rally hard this year.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...